# Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive Bladder

> **NCT00795925** · PHASE2 · COMPLETED · sponsor: **APOGEPHA Arzneimittel GmbH** · enrollment: 30 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** propiverine hydrochloride

## Key facts

- **NCT ID:** NCT00795925
- **Lead sponsor:** APOGEPHA Arzneimittel GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2008-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00795925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00795925, "Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive Bladder". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00795925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*